Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01227057 · ClinicalTrials.gov registry record · NA

Hoarding Older Adults

A NA study of Compulsive Hoarding, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT01227057: Completed NA study of Compulsive Hoarding, sponsored by VA Office of Research and Development.

NCT01227057 is a NA study of Compulsive Hoarding that has completed, run by VA Office of Research and Development. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01227057, a NA study of Compulsive Hoarding, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

The purpose of this investigation is to examine treatment outcome of a new intervention for hoarding in older adults compared to standard case management for hoarding. The new intervention combines exposure therapy and cognitive remediation.

Primary Outcome

Hoarding symptom severity (primary outcome) will be measured using the Savings Inventory-Revised (SI-R), a 23-item self-report measure used to assess common hoarding symptoms. Subtests include excessive clutter, compulsive acquisition, and difficulty discarding. The SI-R has demonstrated good internal consistency, divergent validity, concurrent validity, divergent validity, test-retest reliability in clinical samples with hoarding. The total score will be used for analyses. The range of the tota

Conditions Studied

Interventions

  • BEHAVIORAL Case Management
  • BEHAVIORAL Cognitive Rehabilitation and Exposure Therapy for Compulsive Hoarding

Study Locations (1)

California

  • VA San Diego Healthcare System, San Diego, CA - San Diego

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2010-11
Est. Completion 2015-04
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01227057 record still lists

NCT01227057 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Compulsive Hoarding appearing as the primary indexed condition, and to 2 interventions - of which Case Management is the first listed.

NCT01227057 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01227057 about?

NCT01227057 is a clinical study titled "Hoarding Older Adults". The purpose of this investigation is to examine treatment outcome of a new intervention for hoarding in older adults compared to standard case management for hoarding. The new intervention combines exposure therapy and cognitive remediation.

What is the current status of trial NCT01227057?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2010-11. Estimated completion is 2015-04.

What conditions does trial NCT01227057 study?

This clinical trial studies the following conditions: Compulsive Hoarding.

What interventions are being tested in trial NCT01227057?

The interventions under investigation include: Case Management (BEHAVIORAL), Cognitive Rehabilitation and Exposure Therapy for Compulsive Hoarding (BEHAVIORAL).

Who is sponsoring clinical trial NCT01227057?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01227057 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01227057's enrollment target sits among peer trials

58 1256th of 2000 higher than 740 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01227057, the US trial registry maintained by the National Library of Medicine. NCT01227057 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.